These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 38570148)
1. miR-122-3p targets UBE2I to regulate the immunosuppression of liver cancer and the intervention of Liujunzi formula. Guo Z; Wang Y; Qin W; Heng Y; Chen X; Liu N; Li J; Wu H; Zhou Y; Zhang R; Song S; Wu Z J Ethnopharmacol; 2024 Jul; 329():118081. PubMed ID: 38570148 [TBL] [Abstract][Full Text] [Related]
2. miR-342-3p affects hepatocellular carcinoma cell proliferation via regulating NF-κB pathway. Zhao L; Zhang Y Biochem Biophys Res Commun; 2015 Feb; 457(3):370-7. PubMed ID: 25580008 [TBL] [Abstract][Full Text] [Related]
3. Effect of miR-506-3p on Proliferation and Apoptosis of Airway Smooth Muscle Cells in Asthmatic Mice by Regulating CCL2 Gene Expression and Mediating TLR4/NF-κB Signaling Pathway Activation. Manli W; Hua Q Mol Biotechnol; 2021 May; 63(5):410-423. PubMed ID: 33638773 [TBL] [Abstract][Full Text] [Related]
4. MiR-3663-3p participates in the anti-hepatocellular carcinoma proliferation activity of baicalein by targeting SH3GL1 and negatively regulating EGFR/ERK/NF-κB signaling. Tian J; Li J; Bie B; Sun J; Mu Y; Shi M; Zhang S; Kong G; Li Z; Guo Y Toxicol Appl Pharmacol; 2021 Jun; 420():115522. PubMed ID: 33838155 [TBL] [Abstract][Full Text] [Related]
5. The microRNA-520a-3p inhibits invasion and metastasis by targeting NF-kappaB signaling pathway in non-small cell lung cancer. Fang X; Shi H; Sun F Clin Transl Oncol; 2022 Aug; 24(8):1569-1579. PubMed ID: 35247196 [TBL] [Abstract][Full Text] [Related]
6. MiR-29a-3p Enhances the Viability of Rat Neuronal Cells that Injured by Oxygen-Glucose Deprivation/Reoxygenation Treatment Through Targeting TNFRSF1A and Regulating NF-κB Signaling Pathway. Gao XZ; Zhang ZX; Han GL J Stroke Cerebrovasc Dis; 2020 Nov; 29(11):105210. PubMed ID: 33066952 [TBL] [Abstract][Full Text] [Related]
7. Modified Biejia Jianwan decoction restrains PD-L1-mediated immune evasion through the HIF-1α/STAT3/NF-κB signaling pathway. Tian X; Liu F; Wang Z; Zhang J; Liu Q; Zhang Y; Zhang D; Huang C; Zhao J; Jiang S J Ethnopharmacol; 2024 Mar; 322():117577. PubMed ID: 38104877 [TBL] [Abstract][Full Text] [Related]
8. Upregulation of miRNA-10a-5p promotes tumor progression in cervical cancer by suppressing UBE2I signaling. Gu Y; Feng X; Jin Y; Liu Y; Zeng L; Zhou D; Feng Y J Obstet Gynaecol; 2023 Dec; 43(1):2171283. PubMed ID: 36744815 [TBL] [Abstract][Full Text] [Related]
9. Maimendong and Qianjinweijing Tang (Jin formula) suppresses lung cancer by regulation of miR-149-3p. Jiang Z; Ma Y; Tian T; Sun Y; Chen H; Lu Y; Wu Y; Jiang H; Li W; Li L; Zhou H; Wu M J Ethnopharmacol; 2020 Aug; 258():112836. PubMed ID: 32344160 [TBL] [Abstract][Full Text] [Related]
10. miR-29b-3p suppresses the malignant biological behaviors of AML cells via inhibiting NF-κB and JAK/STAT signaling pathways by targeting HuR. Tang YJ; Wu W; Chen QQ; Liu SH; Zheng ZY; Cui ZL; Xu JP; Xue Y; Lin DH BMC Cancer; 2022 Aug; 22(1):909. PubMed ID: 35986311 [TBL] [Abstract][Full Text] [Related]
11. He L; Xu K; Niu L; Lin L Pharm Biol; 2022 Dec; 60(1):1710-1720. PubMed ID: 36086826 [TBL] [Abstract][Full Text] [Related]
12. NF-κB target microRNAs and their target genes in TNFα-stimulated HeLa cells. Zhou F; Wang W; Xing Y; Wang T; Xu X; Wang J Biochim Biophys Acta; 2014; 1839(4):344-54. PubMed ID: 24418602 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA-19b-3p regulates nasopharyngeal carcinoma radiosensitivity by targeting TNFAIP3/NF-κB axis. Huang T; Yin L; Wu J; Gu JJ; Wu JZ; Chen D; Yu HL; Ding K; Zhang N; Du MY; Qian LX; Lu ZW; He X J Exp Clin Cancer Res; 2016 Dec; 35(1):188. PubMed ID: 27919278 [TBL] [Abstract][Full Text] [Related]
14. KDM1A Promotes Immunosuppression in Hepatocellular Carcinoma by Regulating PD-L1 through Demethylating MEF2D. Wang Y; Cao K J Immunol Res; 2021; 2021():9965099. PubMed ID: 34307695 [TBL] [Abstract][Full Text] [Related]
15. Magnoflorine inhibits the malignant phenotypes and increases cisplatin sensitivity of osteosarcoma cells via regulating miR-410-3p/HMGB1/NF-κB pathway. Wang Y; Shang G; Wang W; Qiu E; Pei Y; Zhang X Life Sci; 2020 Sep; 256():117967. PubMed ID: 32553931 [TBL] [Abstract][Full Text] [Related]
16. Endoplasmic reticulum stress-induced exosomal miR-27a-3p promotes immune escape in breast cancer via regulating PD-L1 expression in macrophages. Yao X; Tu Y; Xu Y; Guo Y; Yao F; Zhang X J Cell Mol Med; 2020 Sep; 24(17):9560-9573. PubMed ID: 32672418 [TBL] [Abstract][Full Text] [Related]
17. miR-132-3p promotes the cisplatin-induced apoptosis and inflammatory response of renal tubular epithelial cells by targeting SIRT1 via the NF-κB pathway. Han S; Lin F; Ruan Y; Zhao S; Yuan R; Ning J; Jiang K; Xie J; Li H; Li C; Rao T; Yu W; Xia Y; Zhou X; Cheng F Int Immunopharmacol; 2021 Oct; 99():108022. PubMed ID: 34339961 [TBL] [Abstract][Full Text] [Related]
18. Mifepristone inhibited tumor progression by disrupting the stability of PD-L1 by miR-127-3p/VAMP2 in ovarian cancer. Gu Y; Zhang Y; Liu J Pak J Pharm Sci; 2022 Jan; 35(1(Special)):393-400. PubMed ID: 35236654 [TBL] [Abstract][Full Text] [Related]
19. Effect of MicroRNA-30e on the Behavior of Vascular Smooth Muscle Cells via Targeting Ubiquitin-Conjugating Enzyme E2I. Zong Y; Wu P; Nai C; Luo Y; Hu F; Gao W; Zhai N; Xu T; Li D Circ J; 2017 Mar; 81(4):567-576. PubMed ID: 28123167 [TBL] [Abstract][Full Text] [Related]
20. MiR-410-3p activates the NF-κB pathway by targeting ZCCHC10 to promote migration, invasion and EMT of colorectal cancer. Ma ZH; Shi PD; Wan BS Cytokine; 2021 Apr; 140():155433. PubMed ID: 33517196 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]